Lifestyle Modification Strategies to Support Those Living with Obesity and Diabetes
Blue Shield of California, Highmark, Intellihealth and NourishedRX discuss how they are mitigating the high costs of GLP-1s with lifestyle interventions such as behavior change, physical exercise, nutritional counseling, coaching to optimize outcomes for members living with obesity and diabetes.
Hear real-life examples and best practices to equip your members with the tools and strategies to achieve lasting success in managing obesity and diabetes beyond the limitations of GLP-1s.
PANELISTS Angie Kalousek Ebrahimi, Senior Director of Lifestyle Medicine, Blue Shield of California
Timothy Law, DO, Chief Medical Officer, Highmark Health
Katherine H. Saunders, M.D., Executive Vice President & Co-Founder, Intellihealth
Lauren Driscoll, Founder & CEO, NourishedRx
Lifestyle Modification Strategies to Support Those Living with Obesity and Diabetes
This episode is sponsored by NourishedRX
NourishedRx is a leading digital health and nutrition company specializing in comprehensive
nutrition solutions for consumer and health plan members living with diabetes, obesity and other
diet-related conditions.
NourishedRx recognized food’s healing and connective power, and partners with healthcare
organizations nationwide to address the nutritional needs of their most vulnerable populations.
The NourishedRx B:B:C health and nutrition platform facilitates and optimizes personalized,
culturally concordant food in addition to the tools necessary to drive lasting behavior change –
leveraging technology so YOU can all deliver at scale.
Beyond diet, NourishedRx engages with health plan members and patients to support their
whole health and lifestyle more broadly. They engage consumers with omnichannel wrap-around support and education, enabling individuals to make informed choices and gain a deeper understanding of the impact of their diet and lifestyle on their overall well-being, empowering them for the long term.
NourishedRx is well suited as an early alternative and/or companion therapy to specialized obesity treatment, including GLP-1 and other Anti-Obesity Medication therapies.
